Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00417703 · ClinicalTrials.gov registry record
Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
A clinical trial, sponsored by Oklahoma State University Center for Health Sciences.
- Completed
- Registry status
- 75
- Enrollment target
NCT00417703: Completed study, sponsored by Oklahoma State University Center for Health Sciences.
NCT00417703 is a clinical trial that has completed, run by Oklahoma State University Center for Health Sciences. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00417703 has completed, sponsored by Oklahoma State University Center for Health Sciences.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
This study will quantify the intraocular pressure elevation in the immediate time period following intravitreous injection. With more widespread use of intravitreous injections in patients that may require several injections per year, it is important to document the sudden increase in intraocular pressure, including the maximum intraocular pressure and the time required for the intraocular pressure to return to baseline. This data may be useful in stimulating additional studies to evaluate the long term ocular effects of repeated intravitreous injections. We hypothesize that the intraocular pressure increases significantly following intravitreous injection and then returns to baseline during the initial thirty minutes following ranibizumab injection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-01 |
What the finished NCT00417703 record still lists
NCT00417703 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00417703 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00417703 about?
NCT00417703 is a clinical study titled "Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab". This study will quantify the intraocular pressure elevation in the immediate time period following intravitreous injection. With more widespread use of intravitreous injections in patients that may require several injections per year, it is important to document the sudden increase in intraocular pr...
What is the current status of trial NCT00417703?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2007-01. Estimated completion is 2008-01.
Who is sponsoring clinical trial NCT00417703?
This trial is sponsored by Oklahoma State University Center for Health Sciences, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia